The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Oak Street Health Inc. shares valued at $4,379,004 were sold by PRICE GEOFFREY M on Feb 22. At $35.61 per share, PRICE GEOFFREY M sold 122,985 shares. The insider’s holdings dropped to 3,874,863 shares worth approximately $137.33 million following the completion of this transaction.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
Also, PRICE GEOFFREY M sold 50,000 shares, netting a total of over 1,766,150 in proceeds. Following the sale of shares at $35.32 each, the insider now holds 3,874,863 shares.
Before that, PRICE GEOFFREY M had sold 7,413 shares from its account. In a trade valued at $263,903, the Chief Innovation Officer traded Oak Street Health Inc. shares for $35.60 each. Upon closing the transaction, the insider’s holdings decreased to 7,413 shares, worth approximately $137.33 million.
As published in a research note from Raymond James on January 12, 2023, Oak Street Health Inc. [OSH] has been rated up from a Mkt perform to an Outperform and the price target has been revised to $35. This represents a -1.26% premium over Thursday’s closing price. Analysts at Raymond James downgraded the stock from ‘”an Outperform”‘ to ‘”a Mkt perform”‘ outlook in a report released in late November. As of November 14, 2022, Morgan Stanley has increased its “an Equal-weight” rating to a “an Overweight” for OSH. Earlier on September 12, 2022, Goldman downgraded its rating. Their new recommendation was “a Neutral” for OSH stock which previously was a “a Buy”.
Analyzing OSH Stock Performance
On Thursday, Oak Street Health Inc. [NYSE: OSH] plunged -0.42% to $35.44. The stock’s lowest price that day was $35.365, but it reached a high of $35.59 in the same session. During the last five days, there has been a surge of approximately 0.17%. Over the course of the year, Oak Street Health Inc. shares have jumped approximately 64.76%. Shares of the company reached a 52-week high of $35.65 on 02/22/23 and a 52-week low of $19.73 on 01/06/23. A 50-day SMA is recorded $27.36, while a 200-day SMA reached $23.59. Nevertheless, trading volume fell to 7.91 million shares from 4.75 million shares the previous day.
Support And Resistance Levels for Oak Street Health Inc. (OSH)
According to the 24-hour chart, there is a support level at 35.34, which, if violated, would cause prices to drop to 35.24. In the upper region, resistance lies at 35.56. The next price resistance is at 35.69. RSI (Relative Strength Index) is 70.92 on the 14-day chart, showing overbought technical sentiment. Moving Average Convergence Divergence (MACD) is at 1.50, which suggests the price will increase in the coming days. Percent R is at 1.97%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
Is Oak Street Health Inc. subject to short interest?
Stocks of Oak Street Health Inc. saw a sharp steep in short interest on Jan 30, 2023 dropping by -0.44 million shares to 19.92 million. Data from Yahoo Finance shows that the short interest on Dec 29, 2022 was 20.36 million shares. A decline of -2.21% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 5.22 of the overall float, the days-to-cover ratio (short ratio) decline to 5.22.
Which companies own the most shares of Oak Street Health Inc. (OSH)?
According to Fidelity Management & Research Co filings, the company currently owns 22,604,465 shares, which is about 9.31% of the total OSH shares outstanding. The investor’s shares have plunged by -1,031,473 from its previous 13-F filing of 23635938.0 shares. With the completion of the sale transaction, Capital Research & Management Co’s stake is now worth $474,344,840. The Vanguard Group, Inc. acquire a 10.18% interest valued at $344.23 million while Capital Research & Management Co purchased a 4,126,350 stake. A total of 0 shares of Oak Street Health Inc. were bought by Route One Investment Co. LP during the quarter, and 576 were bought by Capital Research & Management Co. In its current portfolio, Maverick Capital Ltd. holds 5,413,420 shares valued at $157.31 million.
In terms of Oak Street Health Inc. share price expectations, FactSet research, analysts set an average price target of $35.62 in the next 12 months, up nearly 9.58% from the previous closing price of $35.59. Analysts anticipate Oak Street Health Inc. stock to reach $39.00 by 2023, with the lowest price target being $21.00. In spite of this, 17 analysts ranked Oak Street Health Inc. stock as a Hold at the end of 2023.